期刊文献+

昂丹司琼联合消积理气汤治疗乳腺癌术后化疗所致恶心呕吐疗效观察 被引量:5

下载PDF
导出
摘要 目的观察自拟消积理气汤治疗乳腺癌术后化疗所致的恶心、呕吐的临床效果。方法采用随机对照法,将105例乳腺癌术后化疗患者随机分为2组,均接受6个周期AT方案(表阿霉素、紫杉醇)化疗,化疗前治疗组55例在昂丹司琼注射液等常规治疗基础上加消积理气汤口服止吐,对照组50例单纯用昂丹司琼注射液等常规治疗。结果治疗组与对照组有效率分别为87.27%和68.00%,2组比较差异有统计学意义(P<0.05)。结论昂丹司琼联合消积理气汤可以较好地防治乳腺癌术后化疗引起的恶心、呕吐,该方案安全、有效、易行。
出处 《河北医科大学学报》 CAS 2013年第1期64-66,共3页 Journal of Hebei Medical University
  • 相关文献

参考文献11

  • 1陈振东 孙燕 王肇炎.实用肿瘤并发症诊断治疗学[M].合肥:安徽科学技术出版社,1998.421-456.
  • 2WISER W, BERGER A. Practical management of chemotherapy- induced nausea and vomiting [ J ]. Oncology ( Williston Park ), 2005,19 (5) :637 - 645.
  • 3AAPRO M, et al. Palonosetron is effective in preventing acute and delayed chemotherapy-induced nausea and vomiting in patients recieving highly emetogenic chemotherapy (HEC) [ J ]. Support Care Cancer,2003,11 : A17.
  • 4张晓静,张频.肿瘤化疗所致恶心呕吐的发生机制和药物治疗的研究进展[J].癌症进展,2006,4(4):348-354. 被引量:126
  • 5贡心燕.药理学和药物治疗学(下册)[M].北京:人民卫生出版社,2000.1321-1323.
  • 6WOLF H. Preclinical and clinical pharmacology of the 5-HT3 receptor antagonists [ J ]. Scand J Rheumatol Suppl, 2000, 113 : 37 - 45.
  • 7孙菁.5-羟色胺受体药物与胃肠疾病[J].国外医学(消化系疾病分册),2001,21(1):21-25. 被引量:10
  • 8杨净冶 曹平 等.健脾理气煎剂对大白鼠胃肠微循环影响的观察[J].中西医结合杂志,1989,(10):613-613.
  • 9刘汶 李乾构 危北海.健脾理气冲剂治疗功能性消化不良的疗效观察[J].中国中西医结合脾胃杂志,1999,7(3):981-981.
  • 10陈玉春,高依卿.健脾理气合剂免疫调节作用的探讨[J].中成药,1994,16(1):39-40. 被引量:16

二级参考文献59

  • 1杨金明,郭红梅.黄芪对S1802荷瘤小鼠的免疫增强及抑瘤作用[J].中国实验临床免疫学杂志,1995,7(1):41-44. 被引量:20
  • 2陈志峰,刘少翔,侯浚.癌瘤概念的再认识与中医药治疗研究的思考[J].中国中西医结合杂志,1996,16(6):368-370. 被引量:21
  • 3吴厚生.用^3H-TdR释放法测量细胞介导的细胞毒功能[J].上海免疫学杂志,1987,(4):230-233.
  • 4黄挺 于尔辛.健脾理气中药治疗原发性肝癌的临床和实验研究概况[J].上海中医药杂志,1994,8:40-43.
  • 5[1]Wiser W,Berger A.Practical management of chemotherapy-induced nausea and vomiting.Oncology Williston Park),2005,19:637
  • 6[2]Aapro M,et al.Palonosetron is effective in preventing acute and delayed chemotherapy-induced nausea and vomiting in patients recieving highly emetogenic chemotherapy (HEC)[Abstract].Support Care Cancer,2003,11:A17
  • 7[3]Jordan K,Kasper C,Schmoll HJ.Chemotherapy-induced nausea and vomiting:Current and new standards in the antiemetic prophylaxis and treatment.Eur J Cancer,2005,41:199
  • 8[4]Roila F,Donati D,Tamberi S,et al.Delayed emesis:Incidence,pattern,prognostic factors and optimal treatment.Support Care Cancer,2002,10:88
  • 9[5]website:http//www.mascc.org.Multinational association for supportive care in cancer.Consensus Conference on antiemitic therapy Perugia,2004,March 29-31
  • 10[6]Hesketh PJ,Kris MG,Grunberg SM,et al.Proposal for classifying the acute emetogenicity of cancer chemotherapy.J Clin Oncol,1997,15:103

共引文献180

同被引文献73

  • 1罗雪冰.益气养阴化浊汤改善乳腺癌患者化疗恶心呕吐证的临床观察[J].第四军医大学学报,2007,28(18):1725-1725. 被引量:7
  • 2Roila F, Herrstedt J, Gralla RJ, et al. Prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: guideline update and results of the Perugia conseusus conference [J]. Support Care Cancer, 2011, 19 (Suppl 1) :$63--65.
  • 3Rojas C, Slusher BS. Pharmacological mechanisms o{ 5-HT (3) and taehykinin NK (1) receptor antagonism to prevent chemotherapy-induced nausea and vomiting [J]. Eur J Pharmacol,2012,684(1/3) :1-7.
  • 4Hesketh PJ. Chemotherapy-induced nausea and vomitin[J]. N Engl J Med,2008,358(23) :2482--2494.
  • 5Schwartzberg LS, Jacobs P;Matsouka P, et al. The role of second-generation 5-HT3 receptor antagonists in managing chemotherapy-induced nausea and vomiting in hematological malignancies[J].Crit Rev Oncol Hematol, 2012,83 ( 1 ) : 59 -- 70.
  • 6Likun Z,Xiang J,Yi B,et al. A systematic review and meta- analysis of intravenous palonosetron in the prevention of chemotherapy induced nausea and vomiting in adults [J].Oncologist, 2011,16(2) :207-216.
  • 7Roscoe JA, Morrow GR, Aapro MS, et al. Anticipatory nausea and vomiting[J].Support Care Cancer, 2011,19 (10) : 1533 -- 1538.
  • 8Lindley CM, Hirseh JD, 0i Neill CV, et a|. Quality of tile consequences of chemotherapy-induced emesis[J]. Qual Life Res, 1992,1 (5) : 331-- 340.
  • 9O'Brien BJ, Rusthoven J, Rocchi A, et a]. Impact of chemotherapy-associated nausea and vom{ting on patients' functional status and on costs-survey of five Canadian centres[J]. CMAJ, 1993,149(3) :296--302.
  • 10Ettinger DS, Grunberg SM, Hauber AB, et al. Evaluation of the relative importance of chemotherapeutic and antiemetic ef{icaey in various oncologic settings [J].Support Care Cancer,2009,17(4) :405-411.

引证文献5

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部